Martin & Harris Laboratories Ltd incorporated in 1996 at Gurgaon, Haryana is a part of “Apeejay Group”, India’s oldest and largest business conglomerates. Mrs. Sushma Paul Berlia is one of the co-promoter and presidents of Apeejay Stya & Svran Group. Martin & Harris Laboratories Ltd is promoted by her.
P&L Statement | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Revenue | 168 | 186 | 205 | 146 |
Cost of Material Consumed | 64 | 50 | 47 | 41 |
Gross Margins | 61.9 | 73.12 | 77.07 | 71.92 |
Change in Inventory | 0 | 0 | 0 | 0 |
Employee Benefit Expenses | 13 | 19 | 25 | 24 |
Other Expenses | 31 | 47 | 61 | 55 |
EBITDA | 60 | 70 | 72 | 26 |
OPM | 35.71 | 37.63 | 35.12 | 17.81 |
Other Income | 12 | 26 | 24 | 34 |
Finance Cost | 0 | 0.15 | 0 | 0.6 |
D&A | 3 | 3 | 4 | 5 |
EBIT | 57 | 67 | 68 | 21 |
EBIT Margins | 33.93 | 36.02 | 33.17 | 14.38 |
PBT | 69 | 93 | 92 | 55 |
PBT Margins | 41.07 | 50 | 44.88 | 37.67 |
Tax (2021) | 17 | 23 | 24 | 15 |
PAT | 52 | 70 | 68 | 40 |
NPM | 30.95 | 37.63 | 33.17 | 27.4 |
EPS | 133.33 | 175.44 | 170.43 | 100.25 |
Financial Ratios | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Operating Profit Margin | 35.71 | 37.63 | 35.12 | 17.81 |
Net Profit Margin | 30.95 | 37.63 | 33.17 | 27.4 |
Earning Per Share (Diluted) | 133.33 | 175.44 | 170.43 | 100.25 |
Assets | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Fixed Assets | 13 | 13 | 15 | 18 |
CWIP | 0 | 0.4 | 3 | 0 |
Investments | 112 | 373 | 62 | 70 |
Trade Receivables | 0 | 0 | 1 | 2 |
Inventory | 19 | 24 | 19 | 30 |
Other Assets | 316 | 132.6 | 515 | 542 |
Total Assets | 460 | 543 | 615 | 662 |
Liabilities | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Share Capital | 3.9 | 3.99 | 3.99 | 3.99 |
FV | 10 | 10 | 10 | 10 |
Reserves | 442 | 523 | 589 | 628 |
Borrowings | 5 | 5 | 4 | 8 |
Trade Payables | 5 | 4 | 10 | 17 |
Other Liabilities | 4.1 | 7.01 | 8.01 | 5.01 |
Total Liabilities | 460 | 543 | 615 | 662 |
Cash-Flow Statement | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
PBT | 69 | 93 | 92 | 55 |
OPBWC | 62 | 79 | 72 | 27 |
Change in Receivables | 18 | 0 | -1.3 | -0.6 |
Change in Inventories | 2 | -6 | 5.3 | -12 |
Change in Payables | -6 | 1.5 | 4.5 | 7 |
Other Changes | -206 | 100.5 | -400.5 | 11.6 |
Working Capital Change | -192 | 96 | -392 | 6 |
Cash Generated From Operations | -130 | 175 | -320 | 33 |
Tax | -37 | -23 | -24 | -14 |
Cash Flow From Operations | -167 | 152 | -344 | 19 |
Purchase of PPE | -3 | -2 | -8.2 | -12 |
Sale of PPE | 0 | 0 | 0 | 10 |
Cash Flow From Investment | 178 | -132 | 325.4 | -21 |
Borrowing | -8.5 | 0.7 | 0.2 | 4 |
Divided | -0.8 | -1.4 | -2 | -2 |
Equity | 0 | 0 | 0 | 0 |
Others From Financing | -0.2 | 0 | -0.14 | -1 |
Cash Flow from Financing | -9.5 | -0.7 | -1.94 | 1 |
Net Cash Generated | 1.5 | 19.3 | -20.54 | -1 |
Cash at the Start | 0.7 | 2.3 | 21.32 | 0.8 |
Cash at the End | 2.2 | 21.6 | 0.78 | -0.2 |
Shareholding Pattern | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Chang Investchem Private Limited | 37.53% | 37.53% | 37.53% | 37.53% |
Aessen Private Limited | 20.51% | 20.51% | 20.51% | 20.51% |
Acme Network S.A | 20.07% | 20.07% | 20.07% | 20.07% |
Others | 21.88% | 21.88% | 21.88% | 21.88% |